Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Klonidin as pain relief in eye examination of premature infants - cloROP
2024-512438-14-00Phase 4Authorised
- Sponsor
- Region Örebro län
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of clonidine, sponsored by Region Örebro län. Primary endpoint: PIPP-R score within 30 seconds after eye examination initiation. Planned start Jul 2024; status: authorised.
02
Drugs
clonidine
Beyond the preview
Go deeper on 2024-512438-14-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512438-14-00.